Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 01, 2026
Tesla (TSLA) Holds Near $355 as Attention Moves to Robotaxi and AI Ambitions, Down 21% YTD

Tesla (TSLA) Holds Near $355 as Attention Moves to Robotaxi and AI Ambitions, Down 21% YTD

Key Takeaways

  • Tesla shares traded around $354–$357 in early October 2026, essentially flat over the trailing 30 days despite an active news cycle.
  • The stock remains down roughly 21% year-to-date in 2026, well below its 52-week high of about $499.
  • Investor attention has shifted from quarterly vehicle deliveries toward the company's robotaxi, humanoid-robot, and physical-AI ambitions.
  • Wall Street's Sell ratings on Tesla fell to about 13.1% of analysts, the lowest share since April 2023, while Hold ratings climbed to a multi-year high.
  • Near-term catalysts include third-quarter delivery results and a rescheduled Roadster unveiling.

Current Market Snapshot

Tesla, Inc. (TSLA) has been consolidating in a relatively tight range. From a closing price of approximately $356 on September 1, 2026, shares slipped about 0.5% to around $354 by early October, reflecting a broadly sideways month rather than a sharp directional move. That stability stands in contrast to the stock's longer-term retreat: Tesla remains down roughly 21% for 2026 and trades well below its 52-week high near $499, within a 52-week range of roughly $297 to $499.

Sentiment is notably mixed. Analysts are increasingly reluctant to recommend selling the stock, yet they have not turned decisively bullish, leaving Tesla with a heavy concentration of neutral ratings. The shares continue to command a premium valuation relative to traditional automakers, a premium that now hinges on Tesla's AI and robotics narrative rather than its core automotive business. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Tesla (TSLA) Business Overview and Competitive Position

Tesla designs and manufactures fully electric vehicles, energy-generation and storage systems, and autonomous-driving software. Its lineup includes the Model 3 and Model Y, the Cybertruck, the newly launched Cybercab robotaxi, and the Tesla Semi heavy truck, alongside energy products such as Megapack and the Supercharger network. The company has increasingly positioned itself as an artificial-intelligence and robotics enterprise, with management emphasizing robotaxis, the Optimus humanoid robot, and physical AI as long-term growth engines.

Tesla's vertically integrated model—spanning proprietary batteries, powertrains, software, and in-house manufacturing—remains a competitive strength. The company also benefits from brand leadership in electric vehicles and an expanding energy-storage business. That said, it faces intensifying competition from Chinese automakers such as BYD and NIO, as well as from autonomy rivals including Alphabet's Waymo.

Recent Developments Driving TSLA

Several verified developments shaped investor sentiment over the trailing month. Tesla began delivering its long-delayed Semi electric truck to first customers, including PepsiCo and DHL, roughly nine years after the vehicle was first unveiled. The company did not disclose pricing or near-term production volume at the event, leaving the near-term revenue impact uncertain.

The much-anticipated second-generation Roadster reveal was postponed from October 1 to October 15, with Tesla citing severe weather at the outdoor Texas venue. The vehicle is expected to be a low-volume, high-price showcase product rather than a meaningful unit driver. Meanwhile, third-quarter delivery figures were due in early October, with Wall Street consensus pointing to roughly 460,000 vehicles—down from approximately 497,000 in the same period a year earlier, a quarter that benefited from the expiration of a federal tax credit.

Analyst activity reflected caution around the core auto business. JPMorgan lowered its price target on Tesla to $415 from $445 and trimmed its third-quarter delivery estimate to 482,000 from 516,000, citing softer trends in China and the United States. Goldman Sachs reduced its 2026 delivery forecast to 1.75 million from 1.84 million. At the same time, Bloomberg data showed Sell ratings fell to their lowest share since April 2023, while Hold ratings reached their highest level in more than two years—evidence that analysts are reluctant to bet against Tesla's AI ambitions even as the EV outlook stays under pressure. From what I see, this shift in ratings is worth monitoring closely.

2026 Outlook and What Investors Should Watch

Looking ahead, the most important near-term events include Tesla's third-quarter delivery report and subsequent earnings release, both of which will test whether the automotive business can stabilize margins that fell to about 1.4% operating margin in the second quarter. The rescheduled Roadster event on October 15 may influence sentiment, though its financial impact is expected to be limited.

Beyond the auto business, investors are focused on the commercialization of the Cybercab robotaxi, the ramp of the Optimus humanoid robot toward a target of 1,000 units per week and a broader launch in 2027, and progress on Tesla's in-house AI-chip and compute initiatives. Regulatory developments also matter, including the status of Full Self-Driving approvals in Europe, where a vote was pushed toward the end of the year. Macroeconomic factors—EV demand, pricing competition from Chinese rivals, and interest rates—remain key risks that could weigh on both deliveries and profitability. I'm watching this closely as these factors evolve.

Exploring Tickeron AI Trading Bots

For traders seeking a data-driven perspective on names like Tesla, Tickeron's Trending AI Robots page offers a curated view of the platform's automated trading strategies. Tickeron hosts hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are featured in this section. These bots vary widely in strategy, trading timeframe, and performance metrics, giving users a way to compare approaches suited to different risk profiles and market conditions. In my own research process, I find this section helpful for identifying signals that align with current market conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TSLA

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


TSLA in downward trend: price expected to drop as it breaks its higher Bollinger Band on September 03, 2026

TSLA broke above its upper Bollinger Band on September 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 40 similar instances where the stock broke above the upper band. In 35 of the 40 cases the stock fell afterwards. This puts the odds of success at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TSLA as a result. In 68 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

The Moving Average Convergence Divergence Histogram (MACD) for TSLA turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 38 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TSLA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

TSLA moved above its 50-day moving average on September 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TSLA crossed bullishly above the 50-day moving average on September 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.

Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where TSLA advanced for three days, in 265 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 188 of 237 cases where TSLA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. TSLA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 75 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TSLA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.260) is normal, around the industry mean (8.703). P/E Ratio (330.972) is within average values for comparable stocks, (493.775). Projected Growth (PEG Ratio) (4.273) is also within normal values, averaging (2.450). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. TSLA's P/S Ratio (12.225) is slightly higher than the industry average of (2.589).

Notable companies

The most notable companies in this group are Tesla (NASDAQ:TSLA), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), NIO Inc. (NYSE:NIO).

Industry description

Automobiles continue to be arguably the most popular form of passenger travel in the U.S., and major automobile makers have revenues and market capitalizations running into multi-billions. In recent years, the industry has been experiencing some path-breaking innovations like electric vehicles and self-driving technology. While there are long-standing companies like General Motors, Ford, and Toyota Motors operating in this space, there are also emerging/rapidly growing players like Tesla – which has had a major role in the growing popularity of the electric vehicle market. With technological advancements taking steam in the auto space, we’ve also witnessed collaborations (or talks of potential partnerships) of carmakers with tech behemoths like Google’s subsidiary, Waymo.

Market Cap

The average market capitalization across the Motor Vehicles Industry is 69.67B. The market cap for tickers in the group ranges from 669 to 1.41T. TSLA holds the highest valuation in this group at 1.41T. The lowest valued company is PEVM at 669.

High and low price notable news

The average weekly price growth across all stocks in the Motor Vehicles Industry was -3%. For the same Industry, the average monthly price growth was -19%, and the average quarterly price growth was -26%. SSM experienced the highest price growth at 97%, while DCX experienced the biggest fall at -61%.

Volume

The average weekly volume growth across all stocks in the Motor Vehicles Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was -20% and the average quarterly volume growth was -10%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 60
Price Growth Rating: 72
SMR Rating: 86
Profit Risk Rating: 92
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
TSLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of electric sports cars

Industry MotorVehicles

Industry
Motor Vehicles
Address
1 Tesla Road
Phone
+1 512 516-8177
Employees
134785
Web
https://www.tesla.com
Interact to see
Advertisement
MRSH stock declined approximately -9% over the past 30 days, driven by sector-wide AI disruption fears and analyst downgrades. Over the past quarter, the stock fell around -7%, amid softening insurance rates and declining fiduciary interest income.
MCO stock declined approximately -9% over the last 30 days amid profit-taking, insider selling, and sector-wide concerns in financial data analytics. Over the past quarter, shares fell around -18%, reflecting a correction from January highs despite strong Q4 2025 earnings. Key drivers include post-earnings selloff after Q4 results, analyst price target cuts, and broader market volatility in credit ratings sector.
SNOW stock declined approximately -9% over the last 30 days, from around $168 to $153, amid post-earnings profit-taking and analyst caution despite strong results. Over the past quarter, the stock fell about -31%, from near $223, reflecting broader sector pressures and valuation concerns in cloud software.
WDS stock surged +24% over the past 30 days, driven by a sharp rally in oil and LNG prices amid Middle East supply disruptions, including Strait of Hormuz issues and strikes on Qatar's Ras Laffan facility. Over the past quarter, the stock climbed +55%, reflecting sustained energy market volatility and Woodside's strong production from assets like Sangomar and Pluto LNG.
HMC stock declined -19% over the past 30 days amid major setbacks in EV strategy, including cancellation of North American EV models and up to $15.7 billion in related losses. Over the past quarter, shares fell -18%, driven by persistent auto segment weakness, tariff impacts, and revised FY2026 forecasts to a net loss. Key catalysts include March EV reassessment announcement causing a 5%+ drop, Q3 earnings beat overshadowed by one-time charges and guidance concerns, and Sony-Honda JV EV project halt.
EL stock plunged approximately -39% over the past 30 days amid merger discussions with Puig, tariff pressures, and restructuring costs, marking a highly volatile period. Over the past quarter, the stock is down around -37%, reflecting broader sector headwinds despite earlier quarterly earnings beats. Key drivers include confirmation of potential business combination with Puig sparking uncertainty, ongoing $100 million tariff impacts, and elevated restructuring expenses.
ESLT stock rose +13% over the past 30 days, driven primarily by a blowout Q4 2025 earnings report with revenue up 11% and EPS beating estimates by over 10%. Over the past quarter, shares surged +52%, fueled by a record $28.1 billion order backlog, up significantly year-over-year, amid heightened global defense demand. Geopolitical tensions in the Middle East boosted demand for Elbit's systems, alongside major contract wins totaling hundreds of millions from international clients.
EQT stock rose approximately +10% over the last 30 days, driven by strong Q4 2025 earnings beat, robust free cash flow guidance for 2026, and analyst price target increases. Over the past quarter, shares gained around +23%, fueled by operational efficiencies, natural gas price recovery, and positive sector sentiment amid LNG demand growth.
Robin Energy Ltd is a Cyprus-based shipping company focused on ocean and deep-sea freight transportation. As a holding entity, it acquires, owns, charters, and manages oceangoing tanker vessels worldwide. The core of its business lies in energy transportation services, mainly through handysize tankers and LPG carriers. In the competitive marine shipping industry, RBNE positions itself as a growth-oriented player, expanding its fleet and locking in multi-year charters. Recent developments, such as vessel acquisitions and Bitcoin treasury allocations, leave it exposed to shipping cycles and alternative asset volatility. From what I see, this mix contributes to the erratic stock price behavior we've observed amid shifting global energy demand and freight rates.
NG stock plunged -42% over the past 30 days amid sharp declines from mid-March peaks around $14, driven by profit-taking after a multi-year rally and sector-wide weakness in gold mining stocks. Over the past quarter, the stock is down -14%, reflecting volatility from early-year gains tied to financing successes offset by recent macro pressures and permitting concerns. Key drivers include gold price fluctuations due to interest rate expectations, profit-taking post-240%+ annual surge, and no immediate production revenue despite Donlin Gold project advancements.
CRBU stock declined approximately -10% over the past 30 days, reflecting volatility amid clinical updates and financing concerns. Over the past quarter, the stock rose about +12%, driven by positive earnings beats and pipeline progress. Key drivers include Q4 2025 earnings beat, vispa-cel Phase 3 plans, but offset by cash burn and need for additional capital.
Shares of Viridian Therapeutics (VRDN) are down approximately 32% in premarket trading on March 30, 2026, against a prior closing price of $27.39 on March 27, 2026, implying a premarket price near $18.63. The primary catalyst is the release of topline Phase 3 REVEAL-1 clinical trial data for elegrobart (VRDN-003) in patients with active thyroid eye disease (TED), long anticipated as the company's most critical near-term de-risking event.
SYY shares are trading approximately -6.40% lower in premarket trading on March 30, 2026, from a prior close of $81.80 to roughly $76.56. The primary catalyst is Sysco's announcement of a $29.1 billion definitive agreement to acquire Jetro Restaurant Depot, one of the nation's largest Cash & Carry food wholesalers.
Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies, primarily dendritic cell-based vaccines under its DCVax platform. The company's lead candidate, DCVax-L, targets glioblastoma multiforme (GBM), a lethal brain cancer, following completion of a Phase III trial. DCVax-Direct addresses inoperable solid tumors, with Phase I/II data available. NWBO operates in the competitive immunotherapy sector against players like large-cap biotechs, relying on a proprietary manufacturing process for cost-effective production.
FingerMotion, Inc. (FNGR) operates as a mobile data specialist, delivering mobile payment and recharge platform solutions mainly in China. The company's core revolves around telecommunication products and services, such as top-up recharges, data plans, SMS and MMS services, big data insights for consumer behavior analysis, and rich communication services (RCS) platforms. It also provides value-added products through partnerships with telecom providers and e-commerce platforms.
NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.
Xcel Energy Inc. (XEL) stands out as a major U.S. electric and natural gas utility, serving about 3.7 million electric and 2.2 million natural gas customers across eight states, mainly in the Midwest and West. The company focuses on regulated utilities, handling electricity generation, transmission, and distribution, while increasingly prioritizing renewable sources like wind and solar. Its model centers on steady, regulated returns from infrastructure investments, backed by rate cases and recovery mechanisms.
Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.
The ProShares UltraShort Bloomberg Natural Gas (KOLD) is a leveraged inverse exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the Bloomberg Natural Gas Subindex. This subindex reflects the natural gas segment of the commodities market by tracking futures contracts, primarily the second-month Henry Hub natural gas futures, weighted by liquidity and production. The fund does not invest directly in physical natural gas but uses derivatives like futures contracts and swaps to achieve its objective.
Shares of United Therapeutics (UTHR) are surging approximately +17% in premarket trading on Monday, March 30, 2026, with the market not yet open. The primary catalyst is a landmark Phase 3 clinical trial announcement: the TETON-1 pivotal study of nebulized Tyvaso® (treprostinil) met its primary endpoint for treating idiopathic pulmonary fibrosis (IPF), exceeding the already impressive treatment effects seen in the previously completed TETON-2 study.